Search research articles
Contact Us
Filters
Showing results (81-90 of 155) with videos related to
Page
of 16
Sort By:
ASAIO Transactions
|
July 1, 1989
Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variables
E P Paganini, M H Abdulhadi, J Garcia, et al.
Journal of Clinical Pharmacology
|
December 1, 2022
Population Pharmacokinetics and Exposure-Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus
Chayan Acharya, Mats O Magnusson, Pavan Vajjah, et al.
Acta Pharmaceutica Suecica
|
June 1, 1974
Potential hypolipidemic agents. 8. 2-Chloro-5-piperidinosulphono-3-thiophenecarboxylic acids
B Dafgård, S Gronowitz, G Bondesson, et al.
Pharmacology & Toxicology
|
December 1, 1996
Effects of intermittent and continuous subchronic administration of raclopride on motor activity, dopamine turnover and receptor occupancy in the rat
H Ericson, A C Radesäter, E Servin, et al.
Acta Pharmaceutica Suecica
|
January 1, 1978
Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate
S Gronowitz, R Svenson, G Bondesson, et al.
Lakartidningen
|
April 3, 1974
[Pediatric out-patient care. Results from a prospective survey in a county]
B Hansing, B Hysensjö, B Kjellman, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 11, 2005
Creating space for large secondary alcohols by rational redesign of Candida antarctica lipase B
Anders O Magnusson, Johanna C Rotticci-Mulder, Alberto Santagostino, et al.
Neurobiology of Aging
|
January 1, 1992
Persistent changes in behaviour and brain serotonin during ageing in rats subjected to infant nasal virus infection
A K Mohammed, J Maehlen, O Magnusson, et al.
Acta Pharmaceutica Suecica
|
June 1, 1974
Potential hypolipidemic agents. IX. Heterocyclic compouns related to methyl clofenapate
S Gronowitz, R Svenson, G Bondesson, et al.
Urology
|
December 1, 1974
Renal transplantation. II. Lymphatic complications
L H Banowsky, J Francis, W E Braun, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 155) with videos related to
Sort By:
Page
of 16
ASAIO Transactions
|
July 1, 1989
Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variables
E P Paganini, M H Abdulhadi, J Garcia, et al.
Journal of Clinical Pharmacology
|
December 1, 2022
Population Pharmacokinetics and Exposure-Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus
Chayan Acharya, Mats O Magnusson, Pavan Vajjah, et al.
Acta Pharmaceutica Suecica
|
June 1, 1974
Potential hypolipidemic agents. 8. 2-Chloro-5-piperidinosulphono-3-thiophenecarboxylic acids
B Dafgård, S Gronowitz, G Bondesson, et al.
Pharmacology & Toxicology
|
December 1, 1996
Effects of intermittent and continuous subchronic administration of raclopride on motor activity, dopamine turnover and receptor occupancy in the rat
H Ericson, A C Radesäter, E Servin, et al.
Acta Pharmaceutica Suecica
|
January 1, 1978
Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate
S Gronowitz, R Svenson, G Bondesson, et al.
Lakartidningen
|
April 3, 1974
[Pediatric out-patient care. Results from a prospective survey in a county]
B Hansing, B Hysensjö, B Kjellman, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 11, 2005
Creating space for large secondary alcohols by rational redesign of Candida antarctica lipase B
Anders O Magnusson, Johanna C Rotticci-Mulder, Alberto Santagostino, et al.
Neurobiology of Aging
|
January 1, 1992
Persistent changes in behaviour and brain serotonin during ageing in rats subjected to infant nasal virus infection
A K Mohammed, J Maehlen, O Magnusson, et al.
Acta Pharmaceutica Suecica
|
June 1, 1974
Potential hypolipidemic agents. IX. Heterocyclic compouns related to methyl clofenapate
S Gronowitz, R Svenson, G Bondesson, et al.
Urology
|
December 1, 1974
Renal transplantation. II. Lymphatic complications
L H Banowsky, J Francis, W E Braun, et al.
Page
of 16